Pfizer reduced costs 40% without cutting jobs at a facility in Sweden using an alternative approach to organisational and cultural behaviour, and hopes to do the same at its newly acquired Austrian plant.
Generic drug use in Japan has started to increase but 'brand loyalty' is still a considerable challenge according to industry experts.
A small molecule combination therapy has shown promise in defeating breast cancers resistant to the usual treatments.
Technology transfer is the first step to bringing pharma investments to Africa, says the African Regulatory Network (ARN).
Agilent Technologies has launched a quadrupole-time of flight (Q-TOF) mass spectrometry system for applications including food safety and pharmaceuticals.
A merger with Mylan would “transform the global generics space” says Teva, which has entered a $40bn bid as an alternative to the recently proposed Mylan-Perrigo deal.
The US FDA has hit cancer-drug API maker Yunnan Hande Bio-Tech with a warning letter citing concerns over potential manipulation of quality test data.